Eli Lilly & Co. (LLY) Misses Q4 EPS by 1c, Revenue Beats, FY19 EPS Guidance Misses
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,141.99 +2.36%
EPS Growth %: +40.3%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
OCCI, VIVO, PMCB, More
EPS Growth %: +40.3%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
OCCI, VIVO, PMCB, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $1.33, $0.01 worse than the analyst estimate of $1.34. Revenue for the quarter came in at $6.44 billion versus the consensus estimate of $6.28 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2019 EPS of $5.55-$5.65, versus the consensus of $5.77.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore cuts HPE rating amid 'tougher setup'
- A10 Networks adds ex-Goldman Sachs analyst to its board
- Daré Bioscience publishes Phase 1 sildenafil cream data in men
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
